Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro-Reference-Cited by-同舟云学术

Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro

Published:2011-08-16 Issue:7 Volume:130 Page:1577-1589
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Correale P.,Botta C.,Cusi M.G.,Del Vecchio M.T.,De Santi M.M.,Gori Savellini G.,Bestoso E.,Apollinari S.,Mannucci S.,Marra M.,Abbruzzese A.,Aquino A.,Turriziani M.,Bonmassar L.,Caraglia M.,Tagliaferri P.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference47 articles.

1. The EGFR family and its ligands in human cancer: signalling mechanism and therapeutic opportunities;Yarden;Eur J Cancer,2001

2. The ErbB signaling network: receptor heterodimerization in development and cancer;Olayioye;EMBO J,2000

3. Epidermal growth factor receptor (EGFR) signaling in cancer;Normanno;Gene,2006

4. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis;Porter;Oncogene,1998

5. Tyrosine kinases as targets for cancer therapy;Krause;N Engl J Med,2005

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholangiocarcinoma, sequential chemotherapy, and prognostic tests;Frontiers in Oncology;2024-06-24

2. The role of ferroptosis in radiotherapy and combination therapy for head and neck squamous cell carcinoma (Review);Oncology Reports;2024-04-18

3. Targeting Innate Immunity in Glioma Therapy;International Journal of Molecular Sciences;2024-01-12

4. EGFR inhibitor erlotinib plus monoclonal antibody versus erlotinib alone for first-line treatment of advanced non-small cell lung carcinoma: A systematic review and meta-analysis;International Immunopharmacology;2023-06

5. Cetuximab-conjugated PLGA nanoparticles as a prospective targeting therapeutics for non-small cell lung cancer;Journal of Drug Targeting;2023-04-14